ROC curve analysis revealed that PRIM2 could statistically distinguish lung cancer patients from normal individuals, producing an area under the curve (AUC) of 0.904 (95% CI: 0.880–0.927; p < 0.0001) (Figure 1I). Here, PRIM2 is linked to lung carcinoma.